Rachel K. King

Leeftijd : 61

Vermogen : 663 625 USD

Belangrijkste bedrijven :

Novavax, Inc. -

GlycoMimetics, Inc.

Overzicht

Rachel K. King founded GlycoMimetics, Inc.

She is on the board of Novavax, Inc. and 5 other companies.

In her past career she occupied the position of Principal at Bain & Co., Inc., Executive at NEA Management Co. LLC, Chief Executive Officer of Genetic Therapy, Inc., Executive Vice President at ALZA Corp. and Senior Vice President for Novartis Corp.

Rachel K. King received an undergraduate degree from Dartmouth College and an MBA from Harvard Business School.

Posities en verantwoordelijkheden van Rachel K. King

Naam	Titel	Van
Novavax, Inc. (Biotechnologie & Medisch Onderzoek)	Independent Director	2018
GlycoMimetics, Inc. (Biotechnologie & Medisch Onderzoek)	Director	2021
Biotechnology Innovation Organization	Director	2015
MdBio, Inc.	Director	-
MdBio Foundation	Director	-
University of Maryland Biopark	Director	-

Belangnemingen van Rachel K. King

Naam	Aandelen	%	Totale waarde
GlycoMimetics, Inc. (GLYC) (Biotechnologie & Medisch Onderzoek)	531 206	1,01%	381 937 USD
Novavax, Inc. (NVAX) (Biotechnologie & Medisch Onderzoek)	6 250	0,0080%	281 688 USD

Rachel K. KingPersoonlijk netwerk

Naam	Verwante bedrijven
Daniel M. Junius	GlycoMimetics, Inc. Biotechnology Innovation Organization
Scott E. Koenig	GlycoMimetics, Inc. Biotechnology Innovation Organization
David M. Mott	Novavax, Inc. Biotechnology Innovation Organization
Stanley Erck	Novavax, Inc. MdBio Foundation
Douglas A. Doerfler	Biotechnology Innovation Organization MdBio, Inc.
Christian B. Dinneen-Long	GlycoMimetics, Inc.
John L. Magnani	GlycoMimetics, Inc.
Stephanie R. Irish	GlycoMimetics, Inc.
Lisa V. DeLuca	GlycoMimetics, Inc.
Armand Girard	GlycoMimetics, Inc.